Peptides Preclinical Tier 1
BPC-157
Gastrointestinal protection & systemic tissue repair
View research → Compound Database
Compounds
27 compounds indexed — Tier 1 through Tier 4
Category:
Evidence:
Peptides Preclinical Tier 1
CJC-1295
Growth hormone-releasing hormone analogue
View research → Proteins Preclinical Tier 1
Follistatin-344
Myostatin inhibitor studied for muscle growth via SMAD pathway blockade
View research → Peptides Preclinical Tier 1
GHK-Cu
Skin regeneration & collagen synthesis
View research → Peptides Preclinical Tier 1
GHRP-6
Ghrelin mimetic hexapeptide — strongest appetite stimulation among GHRPs
View research → Peptides Preclinical Tier 1
Hexarelin
Synthetic hexapeptide with GH-releasing and cardioprotective activity
View research → Peptides Preclinical Tier 1
Ipamorelin
Selective growth hormone secretagogue
View research → Peptides Preclinical Tier 1
MOTS-c
Mitochondrial-encoded peptide studied for metabolic regulation and longevity
View research → Coenzymes Preclinical Tier 1
NAD+
Essential coenzyme studied for sirtuin activation, PARP-mediated DNA repair and metabolic aging
View research → Neuropeptides Preclinical Tier 1
Oxytocin
Neuropeptide studied for social bonding, wound healing & pain modulation
View research → Peptides Preclinical Tier 1
PT-141
Melanocortin receptor agonist studied for sexual desire, arousal & CNS-mediated erectile function
View research → Peptides Preclinical Tier 1
Retatrutide
Triple receptor agonist (GLP-1/GIP/glucagon) studied for obesity, type 2 diabetes, and metabolic disease
View research → GLP-1 Agonists Preclinical Tier 1
Semaglutide
GLP-1 receptor agonist for appetite regulation and metabolic optimization
View research → Peptides Preclinical Tier 1
Sermorelin
GHRH analog for endogenous growth hormone stimulation
View research → Peptides Preclinical Tier 1
TB-500
Systemic tissue repair & angiogenesis
View research → Peptides Preclinical Tier 1
Tesamorelin
GHRH analogue studied for visceral fat reduction and GH-axis stimulation
View research → Peptides Preclinical Tier 1
Thymosin Alpha-1
Immune modulation, T-cell maturation & viral defense
View research → Peptides Preclinical Tier 1
Thymosin Beta-4
Actin-sequestering, tissue repair & angiogenesis
View research → Peptides Preclinical Tier 1
Tirzepatide
Dual GIP/GLP-1 receptor agonist studied for type 2 diabetes and obesity
View research → Peptides Preclinical Tier 2
AOD-9604
Fragment peptide studied for fat metabolism and lipolysis
View research → Peptides Preclinical Tier 2
CART Peptide
Endogenous neuropeptide regulating appetite and energy homeostasis
View research → Peptides Preclinical Tier 2
Epitalon
Pineal peptide studied for telomerase activation and longevity
View research → Peptides Preclinical Tier 2
KPV
Tripeptide fragment studied for anti-inflammatory and gut-barrier effects
View research → Peptides Preclinical Tier 2
Melanotan II
Non-selective melanocortin agonist studied for skin pigmentation, with notable sexual-function and safety concerns
View research → Peptides Preclinical Tier 2
Pinealon
Synthetic tripeptide studied for neuroprotection, ROS suppression and cellular resilience
View research → Peptides Preclinical Tier 2
Selank
Tuftsin-derived anxiolytic peptide studied for immune modulation and stress response
View research → Peptides Preclinical Tier 2
Semax
ACTH-derived nootropic peptide studied for BDNF modulation and cognitive performance
View research →More compounds — Tiers 2 through 4 — are being added continuously.